ɫ����

Insights from Dr. Craig Munroe: Why Colonoscopy Is the Preferred Method of Screening

In this ɫ����-sponsored USA Today story, Dr. Craig Munroe, Global Lead for Medical Affairs in GI EndoTherapy at ɫ���� Corporation and board-certified gastroenterologist, highlights the critical importance of early detection in the battle against colorectal cancer. He shares his insights on how colonoscopies can be lifesaving.

ɫ���� Resources for Your EUS Practice

ɫ���� is dedicated to equipping healthcare professionals with resources that support their roles in endoscopic ultrasound (EUS). Our collection of articles and studies feature the latest breakthroughs and techniques in EUS, offering insights on the efficacy of the EUS Fine Needle Biopsy (FNB) device, the potential of EUS-SWE as a reliable diagnostic tool, and tips from our subject matter experts.

Q&A with ɫ����’ CMO John de Csepel: A Professional and Personal Take on Colorectal Cancer Screening

Chief Medical Officer (CMO) and Global Head of Medical and Scientific Affairs at ɫ���� Corporation John de Csepel, MD, talks about his career and health milestones, both of which mark his commitment to advocating for colorectal cancer screening as a means for early detection and treatment.

The Power of Persistence: Championing Early CRC Screening

Working at ɫ����, I am exposed to many conversations about the importance of early detection, diagnosis, and treatment. I hear from survivors, caregivers, and physicians about the rising prevalence of colorectal cancer among younger individuals. These stories reinforced my determination to ensure Ryan received the necessary screening.

My Colonoscopy Story

Joe Faratzis was only 29 years old when he was diagnosed with Stage IV colorectal cancer (CRC). He had no family history of CRC but started experiencing unusual symptoms in January 2019 that led to a series of doctor’s appointments, tests and his eventual diagnosis of rectal cancer.

In Memoriam: Celebrating the Legacy of Pres Judy

We were deeply saddened to hear of the passing of Coleman Preston Judy Jr. (“Pres”), a cherished colleague, mentor, and friend, who dedicated 40 remarkable years of service to ɫ���� Corporation of the Americas. Pres officially retired from ɫ���� in March 2015. As we reflect on his contributions and enduring legacy, we are reminded of the indelible mark he left on our organization and the broader medical community.

Imaging Modalities of the EVIS X1™ Endoscopy System: What’s Everyone Seeing?

To read these publications and other papers on the imaging modalities available on the EVIS X1 endoscopy system, visit our Clinical Studies page!

AI Integrated Wearables for Gut Health Diagnosis: ɫ���� Innovation Ventures Invests in Alimetry

The clinician-founded team behind Alimetry recently announced the close of their Series A2 round of funding to pursue broad commercialization of their AI-powered, wearable device. The Alimetry device is designed to be used as an aid in the diagnosis of gut disorders that have proven difficult to solve using conventional diagnostics and testing.

Would You Have Performed a Colonoscopy and Polypectomy in This High-risk Patient Following a Major GI Bleed?

“This case demonstrates the evolution of the management of colon polyps in the setting of lower GI bleeding,” states Dr. Meisner.
“How so?” you may ask. To find out, read about how Dr. Meisner addresses the substantial polyps he encounters, why he chose to use the ɫ����® SnareMasterTM Plus Snare, and the technique he employed during the procedure.

Seven Reasons Why the HDTV in Your Living Room Should Not Be Used in a Procedure Room

“Most consumer-grade monitors sold today have some kind of network functionality, which presents a major risk to patient safety, as well as a security risk if protected health information (PHI) is accessible outside of hospital IT firewalls on connected devices,” according to Blake Pena, Product Manager for Image Chain and Accessories at ɫ����.

A Patient-first Approach to Improve Bladder Control: ɫ���� Innovation Ventures Invests in Neuspera

ɫ���� Innovation Ventures (OIV) recently announced a Series D investment in Neuspera Medical, Inc. This move underscores OIV’s commitment to investing in pioneering minimally invasive solutions that have the potential to enhance patient care and quality of life.

White Paper Explores the Need for Ergonomic Guidelines in the GI Endoscopy Suite